SkepSkep
All episodes
WSJ What’s News — What Drove Kimberly-Clark’s $40 Billion Deal for Tylenol Maker Kenvue
Not scored yet13m·2025-11-03·News Politics

What Drove Kimberly-Clark’s $40 Billion Deal for Tylenol Maker Kenvue

WSJ What’s News · 4000

P.M. Edition for Nov. 3. In one of the biggest takeovers of the year, Kimberly-Clark has agreed to buy Tylenol maker Kenvue for more than $40 billion. WSJ business reporter Natasha Khan joins to discuss the strategy behind the deal. Plus, Chipotle has invested heavily in courting younger customers. Now, they’re…

Listen in your app
Buzzmeter · cross-platform
Not scored yet

We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.

Hive Vote · Skep listeners
New on SkepAwaiting the hive's first votes

Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.

Rate this episode

Add your vote to the Hive — listeners rate every episode after they finish.

Rate this episode
Recent reviews
  • No reviews yet — be the first.

One great episode in your inbox, daily — free.

One email a day, unsubscribe anytime. No spam, ever.